Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

TFBS Bioscience, Inc. (6939) Financial Statements

TFBS Bioscience, Inc. Financial Overview

TFBS Bioscience, Inc.'s market cap is currently NT$668.76M. The company's EPS TTM is NT$-1.88; its P/E ratio is -10.05; and it has a dividend yield of 0.13%. TFBS Bioscience, Inc. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 193.14MNT$ 180.56MNT$ 231.92MNT$ 252.72MNT$ 160.88M
Gross ProfitNT$ 36.82MNT$ 37.52MNT$ 63.32MNT$ 104.05MNT$ 54.05M
Operating IncomeNT$ -78.00MNT$ -61.23MNT$ -5.45MNT$ 33.77MNT$ 6.01M
EBITDANT$ -19.25MNT$ 2.24MNT$ 64.15MNT$ 68.33MNT$ 32.76M
Net IncomeNT$ -74.52MNT$ -38.67MNT$ 4.91MNT$ 27.69MNT$ 6.12M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 440.82MNT$ 693.92MNT$ 979.35MNT$ 1.03BNT$ 240.91M
Total AssetsNT$ 1.46BNT$ 1.50BNT$ 1.45BNT$ 1.36BNT$ 491.30M
Total DebtNT$ 225.06MNT$ 196.16MNT$ 131.77MNT$ 52.19MNT$ 21.35M
Net DebtNT$ -82.27MNT$ -319.76MNT$ -797.57MNT$ -924.25MNT$ -219.56M
Total LiabilitiesNT$ 294.72MNT$ 265.14MNT$ 187.44MNT$ 126.18MNT$ 66.44M
Stockholders' EquityNT$ 1.16BNT$ 1.23BNT$ 1.26BNT$ 1.24BNT$ 424.86M
Cash Flow
Free Cash FlowNT$ -235.16MNT$ -343.96MNT$ -19.36MNT$ 28.89MNT$ 1.98M
Operating Cash FlowNT$ -9.74MNT$ 28.82MNT$ 36.53MNT$ 78.72MNT$ 21.02M
Investing Cash FlowNT$ -179.60MNT$ -500.97MNT$ -57.63MNT$ -104.75MNT$ -19.36M
Financing Cash FlowNT$ -18.88MNT$ 60.46MNT$ -25.99MNT$ 761.56MNT$ 163.11M

Currency in TWD

TFBS Bioscience, Inc. Earnings and Revenue History

-150M0150M300M-50 %-25 %0 %25 %EarningsProfit Margin202020212022202320242025RevenueEarningsProfit Margin
Income Statement >

TFBS Bioscience, Inc. Liabilities to Assets

0600M1.2B1.8B6 %12 %18 %24 %LiabilitiesLiabilities to Assets202020212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

TFBS Bioscience, Inc. Cash Flow

-750M-500M-250M0250M500M750M1B202020212022202320242025OperatingInvestingFinancing
Cash Flow >

TFBS Bioscience, Inc. Forecast EPS vs Actual EPS

Earnings >